56 related articles for article (PubMed ID: 31059084)
1. Eicosapentaenoic acid suppresses angiogenesis via reducing secretion of IL‑6 and VEGF from colon cancer‑associated fibroblasts.
Ando N; Hara M; Shiga K; Yanagita T; Takasu K; Nakai N; Maeda Y; Hirokawa T; Takahashi H; Ishiguro H; Matsuo Y; Takiguchi S
Oncol Rep; 2019 Jul; 42(1):339-349. PubMed ID: 31059084
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Effects of Eicosapentaenoic Acid on Vascular Endothelial Growth Factor-Induced Monocyte Chemoattractant Protein-1, Interleukin-6, and Interleukin-8 in Human Vascular Endothelial Cells.
Takenoshita Y; Tokito A; Jougasaki M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473995
[TBL] [Abstract][Full Text] [Related]
3. Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer.
Villéger R; Chulkina M; Mifflin RC; Markov NS; Trieu J; Sinha M; Johnson P; Saada JI; Adegboyega PA; Luxon BA; Beswick EJ; Powell DW; Pinchuk IV
Br J Cancer; 2023 Feb; 128(4):537-548. PubMed ID: 36482184
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression.
Hsu WH; LaBella KA; Lin Y; Xu P; Lee R; Hsieh CE; Yang L; Zhou A; Blecher JM; Wu CJ; Lin K; Shang X; Jiang S; Spring DJ; Xia Y; Chen P; Shen JP; Kopetz S; DePinho RA
Cancer Discov; 2023 Dec; 13(12):2652-2673. PubMed ID: 37768068
[TBL] [Abstract][Full Text] [Related]
5. Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line:
Urban L; Novák Š; Čoma M; Dvořánková B; Lacina L; Šáchová J; Hradilová M; Svatoňová P; Kolář M; Strnad H; Březinová J; Smetana K; Gál P; Szabo P
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975220
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast regulates angiogenesis in assembled oral cancer organoid: A possible role of NNMT.
Holkom M; Yang X; Li R; Chen Y; Zhao H; Shang Z
Oral Dis; 2024 Apr; ():. PubMed ID: 38566601
[TBL] [Abstract][Full Text] [Related]
7. α-SMA
Wang Z; Han S; Xu K; Yang Q; Wang X; Tang Y; Shao Y; Ye Y
J Gastroenterol Hepatol; 2023 Dec; 38(12):2111-2121. PubMed ID: 37787084
[TBL] [Abstract][Full Text] [Related]
8. Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study.
Kučera J; Strnadová K; Dvořánková B; Lacina L; Krajsová I; Štork J; Kovářová H; Skalníková HK; Vodička P; Motlík J; Dundr P; Smetana K; Kodet O
Oncol Rep; 2019 Nov; 42(5):1793-1804. PubMed ID: 31545456
[TBL] [Abstract][Full Text] [Related]
9. A Wnt-Induced Phenotypic Switch in Cancer-Associated Fibroblasts Inhibits EMT in Colorectal Cancer.
Mosa MH; Michels BE; Menche C; Nicolas AM; Darvishi T; Greten FR; Farin HF
Cancer Res; 2020 Dec; 80(24):5569-5582. PubMed ID: 33055221
[TBL] [Abstract][Full Text] [Related]
10. Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways.
Li Y; Chen F; Chen J; Chan S; He Y; Liu W; Zhang G
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935835
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer.
Unterleuthner D; Neuhold P; Schwarz K; Janker L; Neuditschko B; Nivarthi H; Crncec I; Kramer N; Unger C; Hengstschläger M; Eferl R; Moriggl R; Sommergruber W; Gerner C; Dolznig H
Angiogenesis; 2020 May; 23(2):159-177. PubMed ID: 31667643
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
Aizawa T; Karasawa H; Funayama R; Shirota M; Suzuki T; Maeda S; Suzuki H; Yamamura A; Naitoh T; Nakayama K; Unno M
Cancer Med; 2019 Oct; 8(14):6370-6382. PubMed ID: 31468733
[TBL] [Abstract][Full Text] [Related]
14. Secretion of high amounts of hepatocyte growth factor is a characteristic feature of cancer-associated fibroblasts with EGFR-TKI resistance-promoting phenotype: A study of 18 cases of cancer-associated fibroblasts.
Suzuki E; Yamazaki S; Naito T; Hashimoto H; Okubo S; Udagawa H; Goto K; Tsuboi M; Ochiai A; Ishii G
Pathol Int; 2019 Aug; 69(8):472-480. PubMed ID: 31339210
[TBL] [Abstract][Full Text] [Related]
15. Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence.
Hossen MN; Rao G; Dey A; Robertson JD; Bhattacharya R; Mukherjee P
ACS Appl Mater Interfaces; 2019 Jul; 11(29):26060-26068. PubMed ID: 31117437
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity.
Sung PJ; Rama N; Imbach J; Fiore S; Ducarouge B; Neves D; Chen HW; Bernard D; Yang PC; Bernet A; Depil S; Mehlen P
Cancer Res; 2019 Jul; 79(14):3651-3661. PubMed ID: 31088838
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.
Maeda M; Takeshima H; Iida N; Hattori N; Yamashita S; Moro H; Yasukawa Y; Nishiyama K; Hashimoto T; Sekine S; Ishii G; Ochiai A; Fukagawa T; Katai H; Sakai Y; Ushijima T
Gut; 2020 Feb; 69(2):243-251. PubMed ID: 31085554
[TBL] [Abstract][Full Text] [Related]
18. AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells.
Harata S; Suzuki T; Takahashi H; Hirokawa T; Kato A; Watanabe K; Yanagita T; Ushigome H; Shiga K; Ogawa R; Mitsui A; Kimura M; Matsuo Y; Takiguchi S
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36734271
[TBL] [Abstract][Full Text] [Related]
19. The Interaction Between Cancer-associated Fibroblasts and Cancer Cells Enhances Bcl-xL and Mcl-1 in Colorectal Cancer.
Maeda A; Takahashi H; Harata S; Watanabe K; Yanagita T; Suzuki T; Ushigome H; Nakai N; Maeda Y; Hirokawa T; Shiga K; Ogawa R; Hara M; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
Anticancer Res; 2022 Mar; 42(3):1277-1288. PubMed ID: 35220217
[TBL] [Abstract][Full Text] [Related]
20. ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5‑fluorouracil by inhibiting repair of DNA damage.
Suzuki T; Hirokawa T; Maeda A; Harata S; Watanabe K; Yanagita T; Ushigome H; Nakai N; Maeda Y; Shiga K; Ogawa R; Mitsui A; Kimura M; Matsuo Y; Takahashi H; Takiguchi S
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35191521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
